Monthly Archives: July 2010

The Livestock Biotech Summit is Coming!

Don’t miss your chance to get the special early-bird registration rate for the 2010 Livestock Biotech Summit.  Registration is now open, and our early-bird discounts will expire on Thursday, July 29, 2010 at 11:59 pm Eastern Daylight Time.  The first-ever Summit of its kind, scheduled for September 28-30, in Sioux Falls, S.D., will provide participants three days of cross-cutting discussions among industry, academic and government leaders. Program highlights include: -A unique workshop tailored specifically to Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Video of Plenary Sessions from BIO's World Congress

BIO’s World Congress on Industrial Biotechnology held 6 plenary sessions, featuring Agriculture Secretary Tom Vilsack and DOE Asst. Secretary Cathy Zoi. Additionally, a World Economic Forum report on the Future of Industrial Biorefineries, detailing the potential economic contribution that industrial biotechnology can make, was presented by Novozymes CEO Steen Riisgaard. And a survey of the industrial biotech and advanced biofuel industry by McKinsey & Co. took the pulse of executives in the industry. In the Read More >

Biofuels & Climate Change  |  1 Comment  |  Email This Post
Tags: , , , , , , , , , , , , , , , , , , ,

1Q Cash Spending – Small Biotechs Still Spending Less

A comparison of cash spent on operations in the 1st quarter of 2010 vs the 1st quarters of 2009 and 2008 for small public biotechs shows a slowing in the precipitous drop seen over the last 2 years. However, the average small biotech is still spending less cash vs. 2008. When compared to 1Q08, the median cash flow from operations (CFO) in 1Q10 is down -40%. From 1Q09, median CFO is down -15%. See chart Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , ,

Maintaining a Healthy Biotech Industry

For emerging biotech companies, the economic climate remains challenging. As of April 2010, 38 percent of public biotech companies were operating with less than a year of cash and 24 percent were operating with six months or less of cash, much higher than historic averages. Investors remain wary of taking risks, particularly given the current volatility in global financial markets, and biotech investments are a risky proposition. A biotech discovery runs a one in 5,000 Read More >

Jim's Corner  |  Leave a comment  |  Email This Post

Biotech Sector Performance Update 1H 2010

In my last update back in April, the broadest Biotech index (the 125 company Nasdaq Biotech Index, NBI) was up 11% for the year and ahead of just about every major sector. One quarter later things look a little different. The NBI is now down 5% and trailing 4 of the 10 S&P sectors (chart 1): However, the spotlight continues to shine on the AMEX Biotech Index (BTK). The BTK is up 8.6% for the Read More >

Inside BIO Industry Analysis  |  1 Comment  |  Email This Post
Tags: , , , ,